Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 4, 1996, Pages 529-539

  Gough, A L ^a   Long, R G ^b   Cooper, B T ^c   Foster, C S ^d   Garrett, A D ^e   Langworthy, C H ^f  

^a WESTON GENERAL HOSPITAL   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^e Cyanamid European Data Centre   (United Kingdom)

^f Cyanamid UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; RANITIDINE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOSCOPY; FEMALE; GASTRITIS; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REFLUX ESOPHAGITIS; STOMACH BIOPSY; VERTIGO; VOMITING;

EID: 0030035185     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.14156000.x     Document Type: Article

References (9)

1. Halvorsen L, Lee FI, Wesdorp ICE, et al. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg at bedtime. Aliment Pharmacol Ther 1989; 3: 171-81.
2. Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux oesophagitis. Results from a double blind, randomised. Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 625-32.
3. Bardhan KD, Hawkey CJ, Long RG, et al. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. Aliment Pharmacol Ther 1995; 9: 145-51.
4. Tytgat GNJ, Nio CY, Schotborgh RH. Reflux oesophagitis. Scand J Gastroenterol 1990; 25 (Suppl. 175): 1-12.
5. Robinson M, Lanza F and Lansoprazole Study Group. Lansoprazole for one year prevents recurrence of erosive reflux oesophagitis. Gastroenterology 1994; 106 (Suppl. 4): A166 (Abstract).
6. Hallerback B, Unge P, Carling L, et al. Omeprazole or ranitidine in long term treatment of reflux oesophagitis. Gastroenterology 1994; 107: 1305-11.
7. Dent J, Yeomans ND, Mackinnon M, et al. Omeprazole vs ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994; 35: 590-8.
8. Lundell L, Backman L, Ekstrom P, et al. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991; 26: 248-56.
9. Bate CM, Booth SN, Crowe JP, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995; 36: 492-8.